Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR5 | Q9H228 | 8/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 6/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23822592 | 0.97 | S1PR5 (0.35) | S1PR5S1PR4ALOX5NPC1CYP1A2 | |
| SCHEMBL23821376 | 0.96 | BRDT (0.36) | S1PR5S1PR4ALOX5NPC1CYP1A2 | |
| SCHEMBL23820944 | 0.93 | BRDT (0.37) | S1PR5S1PR4ALOX5NPC1CYP1A2 | |
| SCHEMBL23822798 | 0.92 | BRDT (0.38) | S1PR5S1PR4ALOX5NPC1CYP1A2 | |
| SCHEMBL23820458 | 0.91 | ALOX5 (0.38) | S1PR5S1PR4ALOX5NPC1CYP1A2 | |
| SCHEMBL23820697 | 0.91 | ALDH1A1 (0.34) | S1PR5S1PR4ALOX5NPC1CYP1A2 | |
| SCHEMBL23820488 | 0.91 | S1PR5 (0.36) | S1PR5S1PR4ALOX5NPC1CYP1A2 | |
| SCHEMBL23821256 | 0.90 | ALOX5 (0.39) | ALOX5NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23820676 | 0.90 | ALOX5 (0.39) | ALOX5NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23820487 | 0.89 | S1PR5 (0.34) | S1PR5S1PR4ALOX5CYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4276924-A1 | ORGANIC LIGHT EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-11-15 | — | — | EP | disclosed |
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| EP-4243102-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| EP-4243100-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| EP-4235829-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-08-30 | — | — | EP | disclosed |
| WO-2023002447-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-26 | — | — | WO | disclosed |
| WO-2023003436-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-26 | — | — | WO | disclosed |
| WO-2022177374-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2022-08-25 | — | — | WO | disclosed |
| WO-2021230714-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2021-11-18 | — | — | WO | disclosed |
| WO-2021230715-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2021-11-18 | — | — | WO | disclosed |
| WO-2021182893-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2021-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, PER2 | S1PR5 4880/4885S1PR4 4868/4885ALOX5 1391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.